These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22122386)

  • 1. Debating the evidence: oral contraceptives containing drospirenone and risk of blood clots.
    Dodd S
    Curr Drug Saf; 2011 Jul; 6(3):132-3. PubMed ID: 22122386
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative risks of venous thromboembolism among users of oral contraceptives containing drospirenone and levonorgestrel.
    Heinemann K; Heinemann LA
    J Fam Plann Reprod Health Care; 2011 Jul; 37(3):132-5. PubMed ID: 21659330
    [No Abstract]   [Full Text] [Related]  

  • 3. ACOG Committee Opinion Number 540: Risk of venous thromboembolism among users of drospirenone-containing oral contraceptive pills.
    Committee on Gynecologic Practice
    Obstet Gynecol; 2012 Nov; 120(5):1239-42. PubMed ID: 23090561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOGC clinical practice guideline. No. 252, December 2010. Oral contraceptives and the risk of venous thromboembolism: an update.
    Reid R;
    J Obstet Gynaecol Can; 2010 Dec; 32(12):1192-1197. PubMed ID: 21176332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of blood clots higher for oral contraceptives with certain progestins.
    Voelker R
    JAMA; 2011 Nov; 306(20):2206. PubMed ID: 22110099
    [No Abstract]   [Full Text] [Related]  

  • 6. Do drospirenone-containing oral contraceptives have a higher risk of VTE?
    Ribowsky JH
    JAAPA; 2011 Aug; 24(8):51-3. PubMed ID: 21850920
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral contraceptives and venous thromboembolism: old questions revisited.
    Dinger J
    J Fam Plann Reprod Health Care; 2009 Oct; 35(4):211-3. PubMed ID: 19849911
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
    Dinger J; Assmann A; Möhner S; Minh TD
    J Fam Plann Reprod Health Care; 2010 Jul; 36(3):123-9. PubMed ID: 20659364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of deep venous thrombosis with oral contraceptives containing drospirenone.
    Dunn N
    BMJ; 2011 Apr; 342():d2519. PubMed ID: 21511807
    [No Abstract]   [Full Text] [Related]  

  • 10. Drospirenone-related venous thromboembolism risk: "the rest of the story".
    Casey PM; Files JA; Mayer AP
    J Womens Health (Larchmt); 2013 May; 22(5):467-8. PubMed ID: 23659485
    [No Abstract]   [Full Text] [Related]  

  • 11. Venous thromboembolism in adolescents associated with drospirenone-containing oral contraceptives - two case reports.
    Toni I; Neubert A; Botzenhardt S; Gratzki N; Rascher W
    Klin Padiatr; 2013 Sep; 225(5):266-7. PubMed ID: 23975850
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.
    Sehovic N; Smith KP
    Ann Pharmacother; 2010 May; 44(5):898-903. PubMed ID: 20371756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of venous thromboembolism with drospirenone-containing oral contraceptives.
    Brown DA; Vartan CM
    Am J Health Syst Pharm; 2011 Jun; 68(11):1003-10. PubMed ID: 21593228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: An Assessment of Risk in First-Time Users and Restarters.
    Larivée N; Suissa S; Coulombe J; Tagalakis V; Filion KB
    Drug Saf; 2017 Jul; 40(7):583-596. PubMed ID: 28382493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives.
    Dinger J; Bardenheuer K; Heinemann K
    Contraception; 2014 Apr; 89(4):253-63. PubMed ID: 24576793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drospirenone Litigation: Does the Punishment Fit the Crime?
    Batur P; Casey PM
    J Womens Health (Larchmt); 2017 Feb; 26(2):99-102. PubMed ID: 27854556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drospirenone-containing oral contraceptive pills and the risk of venous thromboembolism: a systematic review of observational studies.
    Larivée N; Suissa S; Khosrow-Khavar F; Tagalakis V; Filion KB
    BJOG; 2017 Sep; 124(10):1490-1499. PubMed ID: 28276140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Venous thromboembolism in adolescents associated with fourth-generation oral contraceptives].
    Botzenhardt S; Toni I; Rascher W; Neubert A
    Klin Padiatr; 2013 Sep; 225(5):268-76. PubMed ID: 23979828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined hormonal contraceptives and venous thromboembolism: putting the risks into perspective.
    Raymond EG; Burke AE; Espey E
    Obstet Gynecol; 2012 May; 119(5):1039-44. PubMed ID: 22525916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of venous thromboembolism in women taking the combined oral contraceptive: A systematic review and meta-analysis.
    Bateson D; Butcher BE; Donovan C; Farrell L; Kovacs G; Mezzini T; Raynes-Greenow C; Pecoraro G; Read C; Baber R
    Aust Fam Physician; 2016; 45(1):59-64. PubMed ID: 27051991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.